Hi 3,
Fact is PNV have picked all the low hanging fruit and have now the hit competition that
is comparable and has high clinical validation.
Every PNV product apart from Novosorb Major burns has high competition and little clinical validation.
The competition is entrenched and would be buffing surgeons out to ensure their business.
Dont tell me that dont happen.
Aloha.
Livewire Markets Say Sell, page-9
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.29 |
Change
-0.015(0.65%) |
Mkt cap ! $1.590B | |||
| Open | High | Low | Value | Volume |
| $2.34 | $2.35 | $2.27 | $1.152M | 501.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 51 | 22900 | $2.28 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.29 | 12138 | 16 |
View Market Depth
| Last trade - 14.29pm 12/07/2024 (20 minute delay) ? |
| PNV (ASX) Chart |